Advances in clinical trial design: Weaving tomorrow’s TB treatments-Reference-Cited by-同舟云学术

Advances in clinical trial design: Weaving tomorrow’s TB treatments

Published:2020-02-27 Issue:2 Volume:17 Page:e1003059
ISSN:1549-1676
Container-title:PLOS Medicine
language:en
Short-container-title:PLoS Med

Author:

Lienhardt Christian^ORCID,Nunn Andrew^ORCID,Chaisson Richard,Vernon Andrew A.^ORCID,Zignol Matteo,Nahid Payam^ORCID,Delaporte Eric,Kasaeva Tereza^ORCID

Publisher

Public Library of Science (PLoS)

Subject

General Medicine

Reference65 articles.

1. State of the Art. Short-course chemotherapy for pulmonary tuberculosis;W Fox;Am Rev Respir Dis,1975

2. Studies on the treatment of tuberculosis undertaken by the British Medical Research Council Tuberculosis Units, 1946–1986, with relevant subsequent publications;W Fox;Int J Tuberc Lung Dis,1999

3. Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies;S Tiberi;Lancet Infect Dis,2018

4. Driving the Way to Tuberculosis Elimination: The Essential Role of Fundamental Research;C Lienhardt;Clin Infect Dis,2016

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic developments for tuberculosis and nontuberculous mycobacterial lung disease;Nature Reviews Drug Discovery;2024-02-28

2. More Tailored Approaches to Tuberculosis Treatment and Prevention;Annual Review of Medicine;2024-01-29

3. If you want to go far, go together: standardisation and data sharing in TB drug development;The International Journal of Tuberculosis and Lung Disease;2024-01-01

4. Treatment-shortening regimens for tuberculosis: updates and future priorities;Breathe;2023-09

5. Determining the minimum duration of treatment in tuberculosis: An order restricted non‐inferiority trial design;Pharmaceutical Statistics;2023-07-06